Inotiv, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Servicestothe Health Industry
DGXQuest Diagnostics, Inc. 0.61%155.954.7%$164.47m
LHLaboratory Corp. of America Holdings 0.01%296.862.4%$148.10m
IQVIQVIA Holdings, Inc. -0.59%256.330.0%$144.69m
AMEHApollo Medical Holdings, Inc. 3.41%98.400.0%$56.60m
NOTVInotiv, Inc. 6.83%34.720.0%$2.21m
PLXProtalix Biotherapeutics, Inc. 3.03%1.3618.5%$2.00m
NRCNational Research Corp. -0.42%47.760.0%$0.98m
QIPTQuipt Home Medical Corp. -1.34%5.880.0%$0.44m
PMDPsychemedics Corp. -3.39%7.700.7%$0.29m

Company Profile

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.